Getinge AB ser. B

Research Getinge AB ser. B (GETI-B) on Bullrun: valuation model: 17.0% undervalued, market cap SEK 54.43B, P/E 23.1, dividend yield 2.4%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerGETI-B
ExchangeST
CountrySweden
SectorHealthcare
IndustryMedical Devices
CurrencySEK
Valuation signal17.0% undervalued
Market capSEK 54.43B
P/E23.1
Dividend yield2.4%
Financial periodFY2024
RevenueSEK 34.76B
Revenue growth9.2%
Net incomeSEK 1.65B
Gross margin46.5%

Valuation Snapshot

Bullrun's latest valuation model marks Getinge AB ser. B as 17.0% undervalued; latest market cap is SEK 54.43B; P/E is 23.1; dividend yield is 2.4%.

About Getinge AB ser. B

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions.

Frequently asked questions

Is Getinge AB ser. B overvalued or undervalued?

Bullrun's valuation model currently marks Getinge AB ser. B as 17.0% undervalued.

What is Getinge AB ser. B's market cap?

Getinge AB ser. B's market capitalization is SEK 54.43B.

What is Getinge AB ser. B's P/E ratio?

Getinge AB ser. B's price-to-earnings (P/E) ratio is 23.1.

Does Getinge AB ser. B pay a dividend?

Getinge AB ser. B has a dividend yield of 2.4%.